Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePomůže nám nový SGLT2 inhibitor empaglifložin snížit riziko hypoglykemie?AuthorsPelikánová, TereziePublicationInternal Medicine / Vnitrni Lekarstvi, 2014, Vol 60, Issue 12, p1102ISSN0042-773XPublication typeArticle